drugset / Trial / NCT00085306
Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
Phase 2
Completed
21 enrolled
Case Comprehensive Cancer Center
National Cancer Institute (NCI) · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
RATIONALE: Interferon beta may interfere with the growth of tumor cells. PURPOSE: This phase II trial is studying how well interferon beta works in treating patients with metastatic cutaneous (skin) melanoma or ocular (eye) melanoma.
Timeline
- Start
- 2004-04
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon-beta | Protein / enzyme biologic | — | Subcutaneous |